| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
| Sales | 2,107,620 | 1,707,200 | 1,563,100 | 3,854,300 | 3,070,770 |
| Sales Growth | +23.45% | +9.22% | -59.45% | +25.52% | -7.71% |
| Net Income | -825,490 | -33,260 | -13,290 | 71,660 | 42,630 |
| Net Income Growth | -2,381.93% | -150.26% | -118.55% | +68.10% | +108.08% |
Enovis Corp (ENOV)
38.50 x 1 39.07 x 1
Pre-market by (Cboe BZX)
38.88 -0.30 (-0.77%) 03/27/25 [NYSE]
38.50 x 1 39.07 x 1
Pre-market 38.88 unch (unch) 19:00 ET
for Thu, Mar 27th, 2025
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.
Fiscal Year End Date: 12/31